Medications

US makes new Alzheimer's drug more widely accessible

The US drug regulator gave full approval to a new Alzheimer's medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.

Alzheimer's disease & dementia

Recurrent brain trauma may increase Alzheimer's risk

New research finds that the brains of otherwise healthy military personnel who are exposed to explosions show an abnormal brain accumulation of amyloid-beta protein—a protein that plays a role in the development of Alzheimer's ...

Alzheimer's disease & dementia

New insights into eye damage in Alzheimer's disease patients

Cedars-Sinai investigators have produced the most extensive analysis to date of changes in the retina—a layer of tissue at the back of the eye where visual information originates—and how those retinal changes correspond ...

Medical research

Alzheimer's study links cholesterol and toxic protein clusters

Cholesterol tremendously increases the toxicity of a peptide implicated in Alzheimer's progression, according to research by scientists in the Department of Biochemistry and Biophysics in Texas A&M's College of Agriculture ...

page 18 from 38